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PERBANDINGAN PENILAIAN KEBERKESANAN ANTARA HYDROCYN™ 
AQUA DAN LARUTAN “SUPER OXIDIZED” KOMERSIL PADA LUKA DI KAKI 
AKIBAT KENCING MANIS. 
ABSTRAK 
Latar Belakang: 
Pesakit kencing manis secara am nya mempunyai 15% risiko untuk menghidapi luka di kaki 
mereka. Matlamat perawatan adalah untuk mendapatkan penyembuhan luka dengan 
menggabungkan rawatan pembedahan dan bukan pembedahan sekaligus mengurangkan 
risiko amputasi anggota badan. Larutan pembasmi infeksi secara tradisinya digunakan untuk 
pencucian luka namun mempunyai perbezaan pendapat di antara pengamal-pengamal 
kesihatan mengenai kesan toksik kepada sel-sel hos. Hydrocyn™ Aqua merupakan satu 
larutan antiseptik di dalam bentuk larutan “super oxidized” yang stabil dengan pH yang 
neutral dan tempoh tahan simpanan yang panjang.  
 
Objektif: 
Objektif kajian ini adalah untuk membandingkan keberkesanan larutan Hydrocyn™ Aqua 
dengan jenama komersil larutan “super oxidized” di dalam pengurangan saiz luka dan juga 
penyediaan dasar luka. 
 
Cara Kajian: 
Kajian klinikal prospektif terkawal secara rambang dengan kaedah “single blinded” ini 
melibatkan pesakit yang mempunyai penyakit kencing manis, luka kaki akibat kencing manis 
yang dijangkiti kuman dan yang mendapatkan rawatan pembedahan “debridement” di 
Jabatan Ortopedik, Hospital Universiti Sains Malaysia dari Januari 2015 hingga Disember 
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2015. Pesakit-pesakit yang memenuhi kriteria inklusif dan eksklusif di beri rawatan selama 
2 minggu, ditentukan secara rambang sama ada rawatan dengan Hydrocyn™ Aqua (n=30) 
atau larutan “super oxidized” komersil (n=30) menggunakan perisian komputer untuk proses 
perambangan. Pelekat informasi pada kedua-dua botol larutan ditanggalkan supaya pesakit-
pesakit tidak mengetahui rawatan yang diterima. Keputusan kajian ini meliputi data-data 
demografi, saiz luka, pemarkahan dasar luka dan juga komplikasi pada awal rawatan dan 2 
minggu selepas rawatan. 
 
Keputusan: 
Pengumpulan dan analisis data dilakukan menggunakan perisian IBM SPSS Statistic Versi 
22. Keputusan peratusan pengurangan saiz luka di antara kumpulan Hydrocyn™ Aqua dan 
larutan “super oxidized” komersil menunjukkan tiada perbezaan di antara mereka (p = 0.9). 
keputusan pemarkahan dasar luka juga menunjukkan tiada perbezaan yang ketara (p  = 
0.09). Tiada komplikasi direkodkan. 
 
Kesimpulan: 
Tiada perbezaan yang ketara di antara Hydrocyn™ Aqua berbanding larutan “super 
oxidized” komersil di dalam keberkesanan merawat luka di kaki akibat kencing manis 
terutama pada pengurangan saiz luka dan juga penyediaan dasar luka. 
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Evaluation of the Efficacy of Hydrocyn™ Aqua In Comparison To Commercially 
Available Super Oxidized Solution as Dressing Solution for Diabetic Foot Ulcers 
Abstract 
Introduction: 
Diabetic patients will have a 15% of risk of developing diabetic foot ulcers during the disease 
course and usually this is complicated by infections. The principle aim of treatment is to 
promote wound healing combining surgical and non-surgical treatment. Disinfectants have 
been used traditionally but it has the argument of cyto-toxicity against host. Hydrocyn™ 
Aqua is an antiseptic solution in the form of stable super oxidized solution with neutral pH 
and longer shelf life which can be used in the treatment of diabetic foot ulcers. 
 
Objective: 
The objective of this study is to compare the efficacy of Hydrocyn™ Aqua with the 
commercially available super oxidized solution (CASOS) in term of wound size reduction 
and optimal wound bed preparation. 
 
Methodology: 
This was a prospective, single-blinded randomized controlled trial involving patients with 
diabetes mellitus, who attended Orthopaedic Department Hospital Universiti Sains Malaysia 
(HUSM), Kubang Kerian between January to December 2015 which have been surgically 
debrided. Patients who fulfilled the criteria were randomized to receive treatment with 
Hydrocyn™ Aqua (n = 30) or CASOS (n = 30) with daily dressing for 2 weeks. Outcome 
measures include demographic data, size of wounds, wound bed scoring and complications 
at baseline and at 2 weeks. 
xii 
 
Results: 
Wound reduction percentage after 2 weeks of treatment with Hydrocyn™ Aqua and CASOS 
showed no difference in both groups (p= 0.9). The wound bed scoring at 2 weeks of treatment 
showed no difference for both treatments. (p= 0.09) There was no adverse reactions recorded 
for both groups. 
 
Conclusion: 
There is no significant difference for the efficacy of Hydrocyn™ Aqua compared to the 
commercially available super oxidized solution in the treatment of diabetic foot ulcers. 
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CHAPTER 1: INTRODUCTION 
1.1 Problem Statement 
Diabetic foot ulcers is a known foot complications in diabetic patients and may consequently 
result in   amputation rate as well as being life threatening. It has been estimated that around 
15 %  of patients with diabetes will develop lower extremity ulcer during the course of their 
disease (Palumbo PJ, 1995).  The prevalence of foot ulceration in patients attending the 
diabetic outpatient clinics in Malaysia has been reported as 1.2% with almost double increase 
in the figure from year 2011 to 2012(Mustapha and Azmi, 2013).  Diabetic ulcers and its 
complications are a major cause of morbidity, a leading case of hospital bed occupancy and 
account for substantial health care costs and resources(Girod et al., 2003). 
 
The primary treatment goal of diabetic foot ulcers is to ensure wound closure as soon as 
possible. It has been shown that, resolving foot ulcers and decreasing its recurrence rate can 
lower the probability of lower extremity amputation (Girod et al., 2003). For optimum care, 
treatments are mainly combination of surgical and non-surgical. 
 
Wound dressings after wound debridement of infected ulcers plays an important role for 
wound bed preparation and wound healing. Today, there are a variety dressing modalities 
have been developed. Traditionally this was done with just normal saline or povidone iodine 
alone.  
 
Studies have shown that antiseptic solution is more effective than normal saline. Some 
experts argue against the use of antiseptic agents in wound treatment because of its cyto-
toxicity against the host’s dermal and epidermal cells(Luca et al., 2006). 
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In the early 21st century, antiseptic solution in the form of stable super oxidized solution, 
which is produced by electrolysis of water and sodium hydrochloride to generate reactive 
species of chlorine and oxygen was developed. The solution has a neutral pH and a longer 
shelf life. 
 
1.2 Study Justification. 
To date, Dermacyn® has been the only commercially available neutral pH, super oxidized 
solution which is produced by Oculus Innovative Science Inc., United States and widely 
available worldwide. Recently, Vigilenz Medical Devices Sdn Bhd, a Malaysian company, 
began production of a neutral pH super oxidized solutions under the brand name Hydrocyn™ 
Aqua. It can be considered as a generic brand and based on both products information 
pamphlets, there is no significant difference in their properties (Table 1.1). However, the 
previous was produced from oversea and has been in the market for more than 10 years and 
many studies has been done showing its efficacy in the treatment of diabetic foot ulcers. 
Meanwhile, Hydrocyn™ Aqua has only been in the market for less than 5 years and so far 
there are no study, trials or clinical research testing this locally produced super oxidized 
solution. To date only one case report by Harikrishna et al (2012) available, where he reported 
3 cases of infected diabetic foot ulcers and surgically debrided where Hydrocyn™ Aqua was 
used as a wound cleansing and irrigation solution. He found that all the 3 cases had reduced 
smell and there was improvement in terms of infection and the wounds healed well in 
concordance with wound bed preparation(Harikrishna, 2012).  
 
In term of production, both products claim using their own technology of water oxidation 
and electrolysis producing the neutral pH super oxidized solution containing the reactive 
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chlorine and oxygen molecules. However, the details of the technologies used for both 
products could not be found in the literature and queries made to both companies were not 
answered due to their business strategies. 
 
Although both brands have almost the same properties as a neutral pH super oxidized 
solution, the procedures and technologies of water oxidation and electrolysis they used could 
be different. Furthermore, no clinical trial or study has been done to show Hydrocyn™ Aqua 
efficacy as a neutral pH super oxidized solution Therefore, there is a need to investigate 
further Hydrocyn™ Aqua which may offer a better or equally good alternative to the 
commercially available neutral pH super oxidized solution which has proven efficacy in the 
treatment of diabetic foot ulcers. 
 
 
Table 1.1: Components of Hydrocyn™ Aqua and Commercially available super oxidized 
solution 
 Hydrocyn™ Aqua Commercially available super oxidized 
solution 
Electrolyzed water 99.8-99.9% 99.98% 
Hypochlorous acid 0.02-0.03% 0.025% 
Sodium Hypochlorite 0.03-0.04% 0.036% 
Sodium Chloride 0.05% 0.11% 
pH 7.5 6.2-7.8 
 
 
 
 
4 
 
1.3 Benefit of the study 
This study aims to demonstrate that this locally produced super oxidized solution is 
comparable in its efficacy to the commercially available super oxidized solution in terms of 
treatment of diabetic foot ulcers. This may help to reduce the cost of diabetic foot ulcer 
management as Hydrocyn™ Aqua is produced locally and is cheaper. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Diabetic foot 
2.1.1 Definition 
The World Health Organization (WHO) and the International Working Group on the Diabetic 
Foot defined diabetic foot as the foot of a diabetic patient that has the potential risk of 
pathological consequences including infection, ulceration and or destruction of deep tissues 
associated with neurological abnormalities, various degrees of peripheral vascular disease 
and or metabolic complications of diabetic foot ulcers and or metabolic complications of 
diabetes in the lower limb. 
 
2.1.2 Epidemiology 
It has been projected that by 2030 there will be estimated 366 million diabetics worldwide 
(Wild et al., 2004). With increasing number of diabetes patients, there will be an increase in 
the number of diabetic foot. It has been documented that about 15% of diabetic patients will 
develop lower extremity ulcers as the disease progress.  The cost of treating diabetic foot 
ulcers to the patient and healthcare system is enormously high. This has been estimated to be 
USD 20 billion  in the United States (Ramsey et al., 1999). Generally, the prevalence of 
diabetic foot ulcers has been reported to occur in 2 % of the population. National Diabetes 
Registry in 2013 reported that the prevalence of foot ulceration in patients attending diabetic 
outpatient clinics in Malaysia has been reported as 1.2% in 2012 but with increasing number 
of patients from 2011. Diabetic foot ulceration has been considered the most likely predictor 
of eventual lower extremity amputation in patients with diabetes mellitus with 85% of lower 
extremity amputations were preceded by foot ulcers (Palumbo PJ, 1995). 
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2.1.3 Pathophysiology 
Ischaemia and neuropathy are the principle pathophysiology in the development of diabetic 
foot ulcers. The aetiology of foot ulcer classically has been categorized into mainly pure 
neuropathic (60%), neuroischaemia (40%) and lastly pure ischemic in origin (10%)(Clayton 
Jr and Elasy, 2009). However , there is a changing trend in the etiology of diabetic foot ulcers 
where neuroischaemic type is slowly gaining predominance (52%) followed by neuropathic 
(36%) and (11%) ischemic (Oyibo et al., 2001). This might suggest the greater awareness of 
patients and health care providers towards certain categories of foot ulcer aetiology.  
 
Ischemia and neuropathy are the principle pathophysiology in the development of diabetic 
foot ulcers. Both ischemia and neuropathy are frequently the initiating factors of foot ulcers 
with infection as the consequence of these. 
 
In a diabetic foot, all layers of the foot can get involved from the skin, subcutaneous tissue, 
muscles, bones and joints to the blood vessels and nerves.  Development of foot ulcers in 
diabetic patients are multifactorial involving neuropathy, minor foot trauma and foot 
deformity. Other existing risk factors such as uncontrolled hyperglycemia, unable to offload 
pressure over the specific area such as the first metatarsal head, and poor nutrition will 
worsen the wound and impair the healing process. 
 
1. Neuropathy 
A majority ( 60%)  of diabetic foot ulcers are caused by underlying neuropathy (Dyck et al., 
1999). The neuropathy can be either focal or diffuse. The latter is more common and includes 
autonomic neuropathy and chronic sensorimotor polyneuropathies. Sensorimotor 
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polyneuropathy which involves lower extremity symmetrically leads to loss of protective 
sensation for the foot. 
 
The pathomechanics of diabetic neuropathy has been described with regards to the metabolic 
and microvascular components. Hyperglycemia-induced metabolic abnormalities has been 
shown in animal and in vitro models as the main mechanism in the development of 
neuropathy in affected patients (Zochodne, 2008). These hyperglycaemic induced metabolic 
abnormalities has been described as the polyol pathway. Hyperglycemic state leads to an 
increase in enzyme aldose reductase and sorbitol dehydrogenase resulting production of 
sorbitol and fructose from intracellular glucose (Clayton Jr and Elasy, 2009). These 
metabolic products accumulate and in turn result in a decrease in the synthesis of nerve cell 
myoinositol which is required for normal neuron conduction. The conversion of glucose also 
results in depletion of the nicotinamide adenine dinucleotide phosphate storage which is 
important in detoxification of reactive oxygen species and for synthesis of the vasodilator 
nitric oxide. This leads to nerve cell injury and death cause by increase oxidative stress and 
vasoconstriction. Hyperglycemia and oxidative stress also cause abnormal glycation of nerve 
cell proteins and the inappropriate activation of Protein Kinase C resulting in further nerve 
dysfunction and ischemia (Clayton Jr and Elasy, 2009). 
 
The motor nerve fiber damage, specifically to the intrinsic foot muscles leads to an imbalance 
flexion and extension of the intrinsic foot muscles. The small muscles will be atrophied while 
the bigger muscles will only be affected later. This results in the metatarsal phalangeal joint 
pulled in to flexion resulting in clawing of the toes and anatomic foot deformity. Skin 
breakdown will occur over areas of abnormal bony prominences and pressure points will 
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gradually will lead ulceration. These subtle changes, in addition to loss of sensation from the 
neuropathy, may not be noticed by the patients. Thus further repeated assaults and injuries to 
the areas may lead to skin breakdown and ulcer formation. 
 
In autonomic neuropathy there will also be loss of sympathetic tone. With loss of the 
sympathetic tone, there will be an increase in arteriovenous shunting in the foot and 
peripheral arterioles dilatation. Autonomic dysfunction also leads to drying of skin due to 
lack of normal glandular function. This predispose the skin to skin breakdown as a result of 
anhydrosis and cracking of dry skin. 
 
2. Ischemia (Vascular Disease) 
Up to 50% of diabetic foot ulcers are contributed by peripheral vascular disease (Simmons 
and Feldman, 2002). Diabetic patient are four times more common to have peripheral 
vascular disease compared to non-diabetics (Kannel and McGee, 1979). Peripheral vascular 
disease is correlated with poor glucose control and for every 1% increase in hemoglobin A1c, 
there is corresponding increase of 25 - 28% in the relative risk of vascular disease.(Selvin et 
al., 2004) 
 
In diabetes, there is alteration in vascular function at both microvascular and macrovascular 
level. The microvascular involves capillaries and arterioles of all organs such as the kidneys, 
retina and peripheral nerves. This has been described as non-occlusive type. At 
macrovascular level, it is the occlusive type which is caused by atherosclerotic changes of 
the coronary and peripheral arteries. Usually this affects the tibial and peroneal arteries of 
the calf (Clayton Jr and Elasy, 2009). In microvascular or non-occlusive type, there is 
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thickening of the capillary basement membrane which subsequently impaired migration of 
leukocytes and increased the risk of infection (Williamson et al., 1988) 
 
A persistent hyperglycaemic state resulting endothelial cell dysfunction and smooth cell 
abnormalities in the peripheral arteries (Zochodne, 2008). Both condition will lead to lack in 
endothelium derived vasodilators which cause the constriction of the vessels. The 
hyperglycaemic state also is associated with increase in thromboxane A2. Thromboxane A2 
increase the risk for plasma hypercoagulability since it is a vasoconstrictor and platelet 
aggregation agonist(Paraskevas et al., 2008). Development of peripheral arterial disease in 
diabetic patient is also contributed by factors such as smoking, hypertension and 
hyperlipidaemia (Armstrong and Lavery, 1998) 
 
3. Infection 
The above mechanisms, either physiologically or mechanically, increase the risk of ulcer 
formation in diabetic foot. The ulcers which is exposed to the surrounding area and given the 
biological medium of the tissues, are prone to be infected. In diabetic foot ulcers 
management, it is important to understand the anatomy of the affected area as infection may 
spread from one compartment to other compartments in the foot. The infection may cause 
increase in inter compartmental pressure which can impair the capillary blood flow and leads 
to progressive tissue ischemia and necrosis. 
 
The common organism associated with diabetic foot ulcers are the aerobic Gram-positive 
cocci including Staphylococcus Aureus, coagulase negative staphylococci and group B 
streptococci. Gram negative organism frequently cultured are Proteus sp, Escherichia coli, 
10 
 
pseudomonas and other Enterobacteriaceae. Emergence of multiple drug resistant organism 
(MDRO) are on the rise such as Methicillin-Resistant Staphylococcus aureus (MRSA), 
bacteria producing extended spectrum beta-lactamase (ESBL), Pseudomonas aeruginosa 
resistant to ceftazidime and imipenem, and Acinetobacter baumannii resistant to imipenem 
(Hartemann-Heurtier et al., 2004) and brings more challenges to the treatment of infected 
diabetic foot ulcers. 
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2.14 Classification of Diabetic Foot Ulcers 
In diabetic foot ulcers, the wound healing tendency can be evaluated  by accurate 
classification of diabetic foot ulcers (Santema et al., 2015). There are two widely used 
classification system which are the Megitt-Wagner and the University of Texas classification. 
 
1. The Megitt-Wagner system(Wagner, 1981). 
This first ever diabetic specific classification system was produced in 1981 by Wagner. It is 
based on depth of penetration and extent of tissue necrosis. The simple system consists of 6 
grades (Table 2.1) with the first three grades are relating to the depth; making it a popular 
classification among clinicians (Game, 2016). However, it has limitations where neuropathy, 
ischaemia or infection are not addressed. 
 
Table 2.1: Megitt-Wagner classification (1981) 
Grading Features 
0 Pre-ulcer. No open lesion. May have deformities, erythematous, areas of pressure or 
hyperkeratosis 
1 Superficial ulcer. Disruption of skin without penetration of subcutaneous fat layer. 
2 Full thickness ulcer. Penetrates through fat to tendon or joint capsule without deep 
abscess or osteomyelitis. 
3 Deep ulcer with abscess, osteomyelitis or joint sepsis. It includes deep plantar surface 
infections, abscesses, necrotizing fasciitis and tendon sheath infections 
4 Gangrene of a geographical portion of the foot such as toes, forefoot or heel 
5 Gangrene or necrosis of large portion of the foot requiring major limb amputation 
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2. The University of Texas Classification(Lavery et al., 1996). 
This classification was developed in 1996 by Lavery et al at the University of Texas San 
Antonio in response to their observation that poor outcomes are often associated with wounds 
of increasing depth, increasing severity of infection and presence of peripheral vascular 
disease. The University of Texas San Antonio Diabetic Classification uses a system of wound 
grade and stage to categorize wounds by severity (Table 2.2). Higher grades and higher stages 
are associated with worse outcomes (Game, 2016). Although it includes the infection and 
ischaemia in the classification, neuropathy is not part of the classification. However it is still 
widely used in view of its simple designs and clear definition. 
 
Table 2.2: The University of Texas Classification 
Grading Features 
0 Pre or post ulcerative or healed wound 
I Superficial wound not involving tendon, capsule or 
bone 
II Wound penetrating to tendon or capsule 
III Wound penetrating to bone or joint 
Stages 
 
A No Infection or ischemia 
B Infection present 
C Ischaemia present 
D Infection and ischaemia present 
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2.15 Principles of Management 
The management of diabetic foot ulcers crucially requires multidisciplinary approach 
including the podiatrist, dietitian, nurses, general practices, physicians and surgeons. Each 
disciplines are important in diabetic control, recognizing risk and prevention, recognizing 
infection and starting appropriate antibiotics, limb at risk and surgical requirements and 
wound care. 
 
Offloading together with debridement are vital in the healing process of diabetic foot wounds 
(Armstrong et al., 2004). Offloading can be done by a number of methods such as total 
contact cast, half shoes, removable cast walkers, wheelchairs and crutches. The aim of 
offloading is to redistribute force from ulcers sites and pressure points at risk to a wider area 
of contact (Clayton Jr and Elasy, 2009). Patients’ compliance, wound condition and infection 
must be considered in choosing the offloading methods. 
 
Presence of necrotic or unhealthy tissues might preventing the ulcer from healing thus 
requiring surgical debridement. Surgical debridement range from callus removal to removal 
of dead or unhealthy tissues and bones to major or minor amputation which aid in removal 
of colonizing bacteria and allowing assessment of the deep tissues. Removal of surrounding 
callus help in reducing pressure point surrounding the ulcer (Clayton Jr and Elasy, 2009). 
Deep tissue or bone can then be send for culture of colonizing bacteria and sensitivity of the 
colonizing bacteria towards antibiotics. 
 
After surgical debridement, wound debridement is important in aiding the healing process. 
Many modalities have been developed recently such as silver based dressings, hydrocolloid, 
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foam, growth factors and skin substitutes. Wounds size, depth, location, surface and 
discharge are the factors that determine the type of dressings. Wound dressings were done 
traditionally with normal saline or antiseptic solution such as povidone or chlorhexidine. The 
type of wound dressing must be tailored to the individual’s wound factors as described 
before. An ideal wound dressing should contribute to a moist wound environment, absorb 
excessive exudates and does not increase the risk of infection (Foster AVM, 1994) 
 
In the presence of infection, oral or parenteral antibiotic is required. The choice of antibiotic 
will take into consideration of the common organism for empirical treatment and the 
sensitivity of the bacteria to antibiotics from the tissue culture. The common classes of 
antibiotics used includes cephalosporin, fluoroquinolones and penicillin with B-lactamase 
inhibitor (Clayton Jr and Elasy, 2009). In a non-limb threatening infection, oral antibiotic can 
be prescribed to patients with regular follow up. Parenteral antibiotic is required when there 
are presence of limb threatening infection or life threatening and require hospital admission. 
 
Adequate blood supply to the limb is necessary to facilitate wound healing and clearing the 
infection(Clayton Jr and Elasy, 2009). Patients with peripheral vascular disease with 
abnormal ankle brachial systolic index (ABSI) should be referred to the vascular surgeons or 
interventional radiologists. Further identification of the diseased vessels can be assessed 
using angiogram. Base on severity; treatment will range from angioplasty to bypass of the 
diseased artery. Surgical bypass of the lower extremity has demonstrated up to 90% 10 years 
limb salvage rate (Shah et al., 1995). 
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Adjunctive therapies are also available for the treatment of diabetic ulcers such as hyperbaric 
oxygen chambers, granulocytes colony stimulating factor and vacuum assisted dressings. 
Usage of human skin equivalents and a recombinant platelet derived growth factors for 
promoting wound healing are also currently being used. However, there is insufficient 
evidence for implementation of these adjunctive modalities in the treatment of diabetic 
wounds (Lipsky et al., 2004). 
 
Prevention of diabetic foot ulcers also requires a multidisciplinary team approach with 
involvement of the patient. This is done by early detection of the risk factors that can 
contribute to development of diabetic foot ulcers. Regular visits, examination and foot care 
advices by podiatrician can help identifying the risk factors and to start appropriate treatment. 
For patient at risk, use of specialized protective shoes with extra depth and custom-molded 
shoes deemed necessary in order to avoid continuous pressure to deformed areas or ulcers. 
One the most important components in prevention is through patient and healthcare personal 
education. For patients they need to be educated regarding the need for daily foot inspection 
and necessity for early intervention. Compliance to their diabetic medication and adequate 
blood sugar control are also important in preventing complication to foot such as neuropathy 
and angiopathy. For healthcare provider, they need to know the significance of foot lesions, 
the importance of regular foot examination and current concept of diabetic wound 
management. The Primary Care team also plays an important role in ensuring good control 
of blood sugars by regular and proper adjustment of patients’ diabetic medication 
requirement. 
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2.2 Wound Healing 
 Wound can be defined as a breakdown in protective function of the skin where there is a loss 
in continuity of the epithelium with or without loss of underlying tissue following injury to 
the skin or underlying tissue or organs caused by surgery, a blow, a cut, chemicals, heat or 
cold, friction or shear force, pressure or as a result of a disease such as leg ulcers or 
carcinomas (Leaper DJ, 1998). 
 
Wound healing can be defined as a complex and well-orchestrated process of restoring the 
integrity of injured tissues by replacement of dead tissue with viable tissue(Clayton Jr and 
Elasy, 2009). The process can be divided to 4 phases which are hemostasis, inflammation, 
proliferation and remodeling and scar formation. 
 
A wound is considered healed when the connective tissues has been repaired and the wound 
completely re-epithialized by regeneration followed by returns to its normal anatomical 
structure and function without requiring continues drainage or dressing (Clayton Jr and 
Elasy, 2009). 
 
2.2.1 Types of wound healing 
There are three types of wound healing which are primary, delayed primary and secondary 
healing. In primary healing, the healing is by first intention where the wound is closed within 
12 to 24 hours. The wound edges are approximated primarily usually by using sutures, tissue 
glue, tapes or staplers. The wound will usually heal well and gives complete closure since 
the incision only causing focal disruption and damages of the epithelial basement membrane. 
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When the wound is closed after a few days in an open contaminated wound that has been left 
open, this is considered as delayed primary healing. By doing so, the infection can be cleared 
by the host defenses before closure of the wound. The collagen metabolism usually preserved 
and the tensile strength is intact. 
 
In secondary healing, the wound will be left to heal by secondary intention where there is 
usually extensive loss of soft tissue such as in infection or extensive trauma due to degloving 
injuries. The normal skin architecture can’t be regenerated and restored by the epithelial cells 
alone. When left open, ingrowth of granulation tissue from the wound margin followed by 
extracellular matrix with collagen within will occur. The closure of the wound is caused by 
wound contraction and epithelialization. The healing process is slower and might cause 
functional restriction due to wound contraction. 
 
2.2.2 Phases of wound healing 
When there is tissue injury, wound healing will take place in four overlapping phases. These 
phases are haemostasis, inflammation, proliferation and remodeling (Figure 2.1). 
Haemostasis occurs immediately after an injury. Blood component, namely the platelets play 
important roles in this phase where they release alpha granules which contain growth factors 
like platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), epidermal 
growth factor (EGF), transforming growth factor-β (TGF-β) and platelet factor-IV. All these 
growth factors will activate the fibroblast, endothelial cells and macrophages. The 
complement cascade, clotting mechanism, kinin cascade and plasmin generation are also 
activated. The clot formed provides provisional matrix for cellular migration and comprise 
of fibrin, fibronectin, vitronectin, von Willibrand factor and thrombospondin. 
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Figure 2.1: Phases of wound healing. 
 
Taken from Basic Science of Wound Healing (Enoch and Leaper, 2005) 
The inflammation phase can be divided into early and late phases. The early phase occurs 24 
to 48 hours after the injury with the activation of the complement cascade. At this phase, 
neutrophils granulocytes (polymorphonuclear leukocytes) infiltrates the wound from 
surrounding vessels and engulf bacteria and foreign particles. During the same time, basal 
cells will increase their mitotic activity and epithelial cells start to migrate and proliferate 
along the dermis and deposit components of basement membrane. In the late stage, within 
48 to 72 hours, the macrophages take over the important role as the key regulatory cells to 
initiate repair. Besides phagocytosing the bacteria and foreign particles, proteolytic enzymes 
are also released. Growth factors responsible for proliferation of smooth cells and endothelial 
cell resulting in angiogenesis and extracellular matrix by fibroblast are release by 
macrophages. 
 
The proliferation phase starts at day three and continue for two weeks after the injury. It starts 
with fibroblasts migration to the wound which is attracted by various growth factors 
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including platelet-derived growth factor and transforming growth factor-β.  Fibroblasts 
proliferates and produces extracellular matrix. The extracellular matrix contain fibrous 
structural protein (such as collagen and elastin) and adhesive glycoprotein. It provides soft 
tissue turgor, rigidity to bone, adhesion area for cells, regulate growth, movement and 
differentiation of the cells within. At around the third to fifth day, granulation tissue starts to 
form. This appears as pink, soft and granular in appearance. The formation of granulation 
tissue is hallmarked by angiogenesis at site of injury. Epithelization occurs within a few hours 
of injury where the epithelial cells from wound edges migrate over the wound to form a 
complete sheet of cells cover and attach to the matrix below it. In primary healing, it 
completes within 24 hours but in secondary healing, a longer time is required since there is 
a larger epithelial gap is larger. 
 
The remodeling phase begins at the first week and may take up to two years to complete. 
Continuous collagen synthesis and breakdown occurs while the extracellular matrix are 
constantly remodeled and achieve steady state about 21 days after injury (Enoch and Leaper, 
2005). Type 3 collagen replaced type 1 collagen which are usually found abundant on skin 
before injury. All this results in normal epithelization and eventually scar maturation. The 
strength of the scar is 50% of its original tensile strength at three months and 80% maximum 
strength at long term (Enoch and Leaper, 2005). 
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2.2.3 Wound healing in diabetic foot infection 
In diabetic patients, the wound healing cascade more often is interrupted with complications 
and remain in different phases leading to loss of sequence of ideal wound healing processes 
(Loot et al., 2002). The complications include infection, thrombosis and ischemia. Diabetic 
foot ulcers commonly become chronic wound and difficult to heal. 
 
With infected wound, the healing process is unable to proceed unless the source, in this case 
the infection, is removed. Wound debridement, is a surgical process whereby dead tissues 
are removed and antibiotics are essential in order for wound healing to take place. However, 
the heterogenicity of diabetic foot infection made the management approach rather difficult 
and complicated. 
 
As mentioned before, vascular disease is common in diabetic patients. For a wound to heal 
orderly, there has to be a good blood supply surrounding the wound is mandatory. With 
microvascular deficiency, there will be reduction of capillary size, thickening of basement 
membrane and hyaline arteriosclerosis. With inadequate blood supply it is not possible for 
all the components which initiates and support wound healing as mentioned above to cross 
to the wound and initiate wound healing. Important inflammatory reaction against infection 
and delivery of antibiotics will also impaired due to the lack of blood supply. The abnormal 
thickening of the  basement membrane also interferes with physiological exchange and leads 
to altered leucocytes migration, decrease maximal hyperaemia and abnormal autoregulatory 
capacity (Dinh and Veves, 2005) 
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With neuropathic foot, there will also be autonomic neuropathy which will then lead to blood 
flow maldistribution as discussed above. This results in dry and sensitive skin which together 
with repetitive injuries, and in addition to infection, further impair wound healing.  
 
In diabetic patients, some important cells for wound healing might undergone phenotypic 
alteration. It has been shown that fibroblast of diabetic ulcers shows a decrease proliferative 
response to growth factors. In term of infection, some diabetic patients will also have defect 
in host defense against infection especially bacterial infection (Naghibi et al., 1987) for 
example, the macrophages has also been shown to have a reduced cytokines release which 
include tumor necrosis factor, interleukin and vascular endothelial growth factor (Zykova et 
al., 2000) 
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2.3 Super oxidized solution. 
The super oxidized solution is produced from pure water mixed with sodium chloride using 
a multi chambers electrolysis cells with the ability to stabilize the solution via the oxygen 
reduction potential (ORP) stabilization process.  Electrolysis is an electrochemical process 
in which electrical energy is the driving force of chemical reactions where substances are 
decomposed by passing an electric current through them. The history of water electrolysis 
dated back in 1800 and there were already 400 industrial water electrolysis units in use 
(Zoulias et al., 2004). However they have properties of low or high pH, unstable  and short 
shelf life which made them not suitable for human usage (Rutala and Weber, 2001). It was 
mainly used to clean hard inanimate object and also for sterilization of medical devices. 
  
The super oxidized solution is produced using multiple electrode chambers where purified 
water containing trace amounts of chloride are oxidized creating oxidized water. The water 
is then broken down into oxygen, ozone and other oxidized acid and chlorine. Chlorine reacts 
with water forming hypochlorous acid (HOCl) and neutralization with Sodium Hydroxide 
(NaOH) converts a portion of HOCl to Sodium Hypochlorite (NaClo). In simpler words, 
during the electrolysis process, the water molecules are dissociated and reactive species of 
chlorine and oxygen are formed (Gonzalez-Espinosa et al., 2007).  
 
Recent advances in electrolysis process makes the super oxidized solution safer and more 
effective for human usage with a non-toxic neutral pH and a longer shelf life (Jesús et al., 
2007; Luca et al., 2006; Piaggesi et al., 2010a). Components of this solution includes 
superoxide-neutral pH water, chlorine <85 parts per million (ppm), reactive oxygen species, 
free radicals, oxidised water (99%), sodium hypochlorite (<50ppm), hypochlorous acid 
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(<60ppm), hydrogen peroxide (<4ppm), ozone (<0.2ppm), chlorine dioxide (<1.5ppm), 
sodium carbonate (<21ppm) and sodium chloride (<110ppm). 
 
In the treatment of infected diabetic foot ulcers, this neutral pH super oxidized solution has 
the antimicrobial property, improves vascularity of the wound and also promotes healing 
process. Super oxidized solution derives its antimicrobial property from its content of 
reactive oxygen species and free radicals which are similarly produced and released inside 
mitochondria during respiratory burst. During microbial elimination, leucocytes generates 
reactive oxygen species and various microbicidal enzymes and peptides(Jesús et al., 2007). 
With its oxidising capacity, the super oxidized solution are highly reactive with bacterial cell 
wall and membrane component and signals protease activation leading to direct killing of the 
bacteria (Thomson, 2000). It also creates a high concentration of potassium ion environment 
which deactivate the bacterial proteases. 
 
The hypochlorous acid content in super oxidized solution is a highly microbicidal chemical. 
In a normal oxidative stress and body primary and secondary defences, the super oxidized 
solution anion dismutes to form hydrogen peroxide and several other reactive oxygen species 
and reactive intermediates. Catalysed by the granule enzyme myeloperoxidase, hydrogen 
peroxide combine with chloride to form the hypochlorous acid which is highly microbicidal. 
 
Super oxidized solution  has electrical energy that able to destroy microorganism including 
fungi, viruses, mycobacteria, spirochetes and bacteria (Thomson, 2000). It kills them in short 
periods of time from seconds to few minutes (Gonzalez-Espinosa et al., 2007).The former 
acidic or alkalotic super oxidized solution loses its electrical potential and its germicidal 
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action when come into contact with multicellular organic matter and turn back into ordinary 
water. A neutral pH super oxidized solution is more effective in retaining its germicidal 
action in this situation because of the trigger of reactive oxygen species in a potassium and 
pH dependant mechanism (Jesús et al., 2007) 
 
The healing properties of super oxidized solution has hypothetically arise from the reactive 
oxygen species which might trigger early wound healing through fibroblast migration and 
proliferation (Yahagi et al., 2000). It also aids in improving wound bed vascularity by 
increasing capillary perfusion and acceleration of angiogenesis. 
 
Most chemical disinfectants used for current wound for example hypochlorite, 
chlorohexidine and povidone iodine, may cause damage to the skin or granulation tissue. 
This can lead to interference with wound healing process and also could be cytotoxic or 
deleterious for the underlying tissues or proximal skin (Fowler et al., 1999; Nakae and Inaba, 
2000). The traditional dressing with normal saline is considered non cytotoxic but inadequate 
to remove surface contaminate and does not have antiseptic properties to control infection 
(Jesús et al., 2007). Study on super oxidized solution toxicity showed that it does not alter 
DNA or RNA stability and produce only limited damage to plasma membranes of fibroblast 
with no effects to cell nuclei (Gonzalez-Espinosa et al., 2007). The same study also showed 
the neutral pH super oxidized solution does not accelerate ageing in fibroblast after 1 month 
of exposure. 
 
The problem with the previous super oxidized solution is its stability once exposed to the 
environment ranging from a few hours to days only. Aging studies for neutral pH super 
